相关实验视频

Updated: Jan 10, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

局部化水凝介导的多西 - 碳白组合化疗向瘤代谢,以减轻瘤的进展

Mohammad Nafees Ansari^1,2, Jasleen Kaur², Ali Khan¹

¹Amity Institute of Integrative Sciences and Health, Amity University Haryana, Panchgaon, Manesar, Gurgaon, Haryana 122413, India.

ACS pharmacology & translational science

|November 20, 2025

概括

使用多塞塔克塞尔,卡博普拉丁和水凝 (DTX-CPT-Gel) 的三阴性乳腺癌 (TNBC) 治疗降低了关键的化物. 这种脂向方法影响生长因子信号,为TNBC治疗提供了一种新的策略.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学
生物化学生物化学

背景情况:

类固醇是癌症进展中信号通路的关键调节者.
三重阴性乳腺癌 (TNBC) 呈现出独特的病理生理学,原因是类固醇失调.
之前的研究已经确定了用于瘤回归的多塞和卡博普拉丁 (DTX-CPT-Gel疗法) 的水凝介导局部递送.

研究的目的:

为了研究DTX-CPT-Gel治疗对TNBC中的氏体代谢的影响.
阐明改变类胺代谢对生长因子受体信号通路的影响.
为了识别TNBC的氏体代谢途径中的潜在治疗点.

主要方法:

在临床前TNBC模型中使用了DTX-CPT-Gel疗法.
分析了氏体水平 (GM3,GD3,GM1) 和它们的代谢基因表达.
评估了信号通路的活性,包括EGFR和cMET/HGFR.

主要成果:

通过DTX-CPT-Gel治疗显著降低了GM3,GD3和GM1类的调节.
该疗法向了在转录和转化层面的类胺代谢基因.
改变的化物代谢调节了EGFR和cMET/HGFR信号通路,有助于瘤缓解.

结论:

DTX-CPT-Gel疗法有效地拦截了TNBC中的多种脂质介导信号通路.
这种治疗方法显示了通过向类胺代谢来治疗TNBC的前景.
GD3合成酶/ST8SIA1成为TNBC的潜在治疗标.

关键词:

乳腺癌乳腺癌乳腺癌化疗化疗是一种化学疗法.药物耐药性耐药性药物耐药性团结体的代谢团结体的代谢

更多相关视频

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.